PCVXVaxcyte, Inc.

PCVX Stock Price, Valuation & Chart | Vaxcyte, Inc.

Compare

$63.620-1.65 (-2.53%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology

Overview Financials Dividends Ratios

PCVX Historical price chart

PCVX Key Stats

Market Capitalization9.76B

PE Ratio-8.34

EPS-7.63

Trading Volume3.25M

Today's High/Low64.89/62.56

Dividend Yield0.00

52 Week High/Low90.75/39.87

Shares Outstanding153.37M

PCVX Financial Statement

PCVX Analyst ratings

PCVX Analysis & performance metrics

PCVX Company profile

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate…

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against…

PCVX Management team

Name

Position

Whitney Jones

Chief People Officer

Sam Iki

Senior Vice President of Project Management

Andrew L. Guggenhime M.B.A.CFO

President & Chief Financial Officer

Janet Graesser

Senior Vice President of Corporate Communications & Investor Relations

Harp Dhaliwal M.B.A.

Chief Technical Operations Officer

Mikhail Eydelman J.D.

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

Grant E. Pickering M.B.A.CEO

Co-Founder, Chief Executive Officer & Director

James Wassil M.B.A., M.S.COO

Executive Vice President & Chief Operating Officer

Name

Position

Whitney Jones

Chief People Officer

Sam Iki

Senior Vice President of Project Management

Andrew L. Guggenhime M.B.A.CFO

President & Chief Financial Officer

Janet Graesser

Senior Vice President of Corporate Communications & Investor Relations

Harp Dhaliwal M.B.A.

Chief Technical Operations Officer

Mikhail Eydelman J.D.

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

Grant E. Pickering M.B.A.CEO

Co-Founder, Chief Executive Officer & Director

James Wassil M.B.A., M.S.COO

Executive Vice President & Chief Operating Officer

Management Team

Whitney Jones

Chief People Officer

Sam Iki

Senior Vice President of Project Management

Andrew L. Guggenhime M.B.A.CFO

President & Chief Financial Officer

Janet Graesser

Senior Vice President of Corporate Communications & Investor Relations

Harp Dhaliwal M.B.A.

Chief Technical Operations Officer

Mikhail Eydelman J.D.

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

Grant E. Pickering M.B.A.CEO

Co-Founder, Chief Executive Officer & Director

James Wassil M.B.A., M.S.COO

Executive Vice President & Chief Operating Officer

Management

Whitney Jones

Chief People Officer

Sam Iki

Senior Vice President of Project Management

Andrew L. Guggenhime M.B.A.CFO

President & Chief Financial Officer

Janet Graesser

Senior Vice President of Corporate Communications & Investor Relations

Harp Dhaliwal M.B.A.

Chief Technical Operations Officer

Mikhail Eydelman J.D.

Senior Vice President, General Counsel, Chief Compliance Officer & Corporate Secretary

Grant E. Pickering M.B.A.CEO

Co-Founder, Chief Executive Officer & Director

James Wassil M.B.A., M.S.COO

Executive Vice President & Chief Operating Officer

Total 8 executives

PCVX Frequently asked questions

What is Vaxcyte, Inc. (PCVX) Stock Price?

Current stock price of Vaxcyte, Inc. (PCVX) stock is $63.620. The stock price is -2.53% lower in the session. The intraday range can be seen from this page. Volume of Vaxcyte, Inc. (PCVX) stock is 3.25M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Vaxcyte, Inc. (PCVX) stock price going up or down today?

The stock price of Vaxcyte, Inc. (PCVX) can change with earnings, company news, and overall market sentiment. Vaxcyte, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Vaxcyte, Inc. stock expensive at its current price?

Whether Vaxcyte, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PCVX on this page is -8.34. EPS on this page is -7.63. Compare those figures with peers and growth expectations before deciding if the current Vaxcyte, Inc. price is justified.

How has the stock price of Vaxcyte, Inc. (PCVX) performed historically?

Historical performance for Vaxcyte, Inc. (PCVX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PCVX reacted to past earnings and market events.

Should I buy Vaxcyte, Inc. (PCVX) stock, at this price?

Buying Vaxcyte, Inc. (PCVX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.